NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) will present at the 2011 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2011, in New York. Elliott Sigal, executive vice president, chief scientific officer and president, Research & Development, will make a presentation about the company at 9:10 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Bristol-Myers Squibb CompanyMedia:Jennifer Fron Mauer, 609-252-6579jennifer.mauer@bms.comorInvestors:John Elicker, 609-252-4611john.elicker@bms.com